Skip to main content
    M

    Myomo Inc (MYO)

    Official site

    HEALTHCARE • MEDICAL DEVICES • AMEX

    $1.03
    -0.20 (-16.26%)

    Market Cap: $49.32M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Myomo Inc (MYO) Financials: Revenue, Profit and Cash Flow

    Updated Nov 9, 2026. Financial statements from company filings, amounts in US dollars.

    Myomo reported revenue of $40.93M for the fiscal year ended Dec 31, 2025, up 25.7% from the year before. That year, net income was -$15.57M with a net margin of -38.1%, operating cash flow was -$14.51M and free cash flow was -$17.84M. The quarter ended Sep 30, 2026 had revenue of $12.33M and net income of -$4.23M.

    Revenue and Margins

    The operating margin was -35.2% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $1.10M, a compound annual rate of 49.5%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$40.93M+25.7%65.7%-35.2%-38.1%
    Dec 2024$32.55M+69.2%71.2%-19.1%-19.0%
    Dec 2023$19.24M+23.7%68.5%-42.8%-42.3%
    Dec 2022$15.56MN/A65.9%-68.6%-68.9%
    Dec 2021$0-100.0%N/AN/AN/A
    Dec 2020$7.58M+97.6%65.7%-138.5%-152.5%
    Dec 2019$3.84M+57.0%63.0%-281.3%-279.1%
    Dec 2018$2.44M+56.8%70.2%-430.8%-422.1%
    Dec 2017$1.56M+41.3%67.6%-420.1%-776.0%
    Dec 2016$1.10MN/A74.4%-296.8%-327.8%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$40.93M$32.55M$19.24M$15.56M$0$7.58M$3.84M$2.44M$1.56M$1.10M
    Cost of revenue$14.04M$9.37M$6.06M$5.30M$3.54M$2.60M$1.42M$728.28K$505.28K$282.16K
    Gross profit$26.89M$23.19M$13.18M$10.25M$10.31M$4.98M$2.42M$1.72M$1.05M$821.11K
    Research and development$6.94M$4.77M$2.64M$2.48M$2.56M$1.67M$1.75M$1.84M$1.75M$1.12M
    Operating income-$14.40M-$6.21M-$8.23M-$10.67M-$24.12M-$10.50M-$10.80M-$10.53M-$6.55M-$3.28M
    Net income-$15.57M-$6.18M-$8.15M-$10.72M-$24.23M-$11.56M-$10.71M-$10.32M-$12.10M-$3.62M
    EBITDA-$11.94M-$5.51M-$7.83M-$10.13M-$23.81MN/A-$10.45M-$10.50M-$6.40M-$3.26M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$12.33M$11.70M$10.11M$11.35M$10.09M$9.65M$9.83M$12.07M$9.21M$7.52M$3.75M$4.76M
    Gross profit$8.79M$8.44M$6.90M$7.78M$6.44M$6.05M$6.61M$8.62M$6.95M$5.33M$2.30M$3.10M
    Operating income-$1.72M-$2.25M-$3.16M-$2.77M-$3.52M-$4.59M-$3.52M-$245.31K-$957.55K-$1.12M-$3.89M-$2.43M
    Net income-$4.23M-$4.02M-$3.01M-$3.81M-$3.66M-$4.63M-$3.47M-$260.08K-$966.41K-$1.12M-$3.84M-$2.46M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $11.22M by $2.91M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$38.64M$42.24M$14.58M$10.16M$20.10M$14.71M$6.60M$8.28M$13.97M$1.66M
    Current assets$27.56M$32.79M$13.65M$9.22M$19.09M$14.45M$6.15M$7.87M$13.85M$1.15M
    Cash and equivalents$14.13M$24.37M$6.87M$5.35M$15.52M$12.24M$4.47M$6.54M$12.96M$797.17K
    Total liabilities$27.23M$17.53M$5.59M$3.80M$4.69M$3.14M$4.77M$1.86M$1.53M$6.52M
    Short-term debt$0$748.02K$486.14K$353.70K$333.38K$18.29K$1.76M$1.32M$39.93K$876.46K
    Long-term debt$11.22M$0N/AN/AN/A$0$888.96KN/A$0$2.20M
    Shareholder equity$11.40M$24.71M$8.99M$6.36M$15.41M$11.57M$1.82M$6.43M$12.45M-$17.53M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$33.80M$35.34M$36.75M$38.64M$34.08M$38.67M$40.87M$42.24M$16.31M$16.19M$16.52M$14.58M
    Total liabilities$31.05M$29.51M$27.75M$27.23M$19.45M$21.06M$19.18M$17.53M$7.02M$6.51M$5.62M$5.59M
    Cash and equivalents$11.10M$11.22M$11.40M$14.13M$12.55M$14.24M$19.79M$24.37M$6.62M$5.85M$5.43M$6.87M
    Shareholder equity$2.75M$5.83M$9.00M$11.40M$14.63M$17.62M$21.69M$24.71M$9.29M$9.68M$10.90M$8.99M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$14.51M-$3.29M-$6.17M-$10.23M-$9.55M-$9.03M-$10.34M-$9.61M-$6.15M-$3.20M
    Capital expenditures$3.33M$1.36M$145.82K$111.79K$326.46K$45.75K$51.99K$126.87K$67.00K$1.86K
    Free cash flow-$17.84M-$4.65M-$6.32M-$10.35M-$9.87M-$9.08M-$10.39M-$9.73M-$6.22M-$3.20M
    Dividends paidN/AN/AN/AN/AN/A$1.85K$2.71MN/A$0N/A
    Investing cash flow-$7.06M$259.98K-$2.03M-$310.79K-$326.46K-$45.75K-$51.99K-$126.87K-$67.00K-$1.86K
    Financing cash flow$11.43M$20.93M$9.71M$376.86K$13.17M$16.78M$8.32M$3.34M$18.38M$2.96M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$1.31M-$1.94M-$2.20M-$1.14M-$1.83M-$8.87M-$2.68M$3.37M-$1.49M-$1.92M-$3.25M-$2.36M
    Capital expenditures$80.25K$77.58K$494.35K$352.22K$1.05M$1.26M$670.69K$860.25K$320.70K$119.36K$59.81K$31.66K
    Free cash flow-$1.39M-$2.02M-$2.69M-$1.49M-$2.88M-$10.12M-$3.35M$2.51M-$1.81M-$2.04M-$3.31M-$2.39M
    Last 12 quarters

    Frequently Asked Questions About MYO

    What is Myomo's annual revenue?

    Myomo reported revenue of $40.93M for the fiscal year ended Dec 31, 2025.

    How fast is Myomo's revenue growing?

    Revenue was up 25.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 38.1%.

    Is Myomo profitable?

    No. Myomo reported net income of -$15.57M for the fiscal year ended Dec 31, 2025, with a net margin of -38.1%.

    How much free cash flow does MYO generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$14.51M minus capital expenditures of $3.33M produced free cash flow of -$17.84M.

    How much debt does Myomo have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $11.22M, short-term debt of $0 and cash and equivalents of $14.13M.